AutoSet CS PaceWave | ResMed
AutoSet CS PaceWave
Patients and Families > Products > Devices > AutoSet CS PaceWave

AutoSet CSTM PaceWaveTM*

AutoSet CSTM PaceWaveTM*

This product may not be available in all countries.


The AutoSet CS™ PaceWave™ is a highly-responsive adaptive servo-ventilator (ASV) that is suitable for a range of central breathing disorders.

Our intelligent PaceWave technology continuously monitors your breathing with split-second accuracy and responds rapidly to stabilise your breathing and meet your specific needs. This unique technology also ensures very natural breathing patterns, providing you with greater comfort.

The AutoSet CS PaceWave is built on our award-winning S9 platform. It features Climate Control, to optimise humidification and protect you from uncomfortable side effects like dry mouth. Thanks to remarkably quiet Easy-Breathe technologies, you'll also enjoy a peaceful sleeping environment.


Key features

  • The Autoset CS PaceWave is easy to set up and operate. It looks like a discreet, elegant alarm clock and features straightforward menu options and user-friendly controls.
  • To optimise your treatment, we have made it easy for your physician to access and analyse your treatment data on-screen, or download high-resolution, breath-by-breath data for deeper insight.
  • The Autoset CS PaceWave offers a ramp functionality to help you comfortably transition into sleep.
  • Our Pressure Support system adjusts automatically to provide exactly the amount of assistance you need. It lets you breathe naturally and spontaneously when that's possible, and steps up with extra support when you need it.

How to buy

After receiving your official diagnosis from your physician, you can get your mask and device from your care provider. For a list of local care providers in your area, please contact us.

More products

The AutoSet CS-A PaceWave is a highly responsive adaptive servo-ventilator with alarms that is suitable for a range of central breathing disorders.

Adaptive servo-ventilator device.

* ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.